drugset / Trial / NCT01015742
Unrelated Double Umbilical Cord Blood Units Transplantation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and feasibility of unrelated double umbilical cord blood units Transplantation in patients with haematological malignancies using Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin, methylprednisolone as GVHD prophylaxis.
Timeline
- Start
- 2009-11
- Primary completion
- 2012-12
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Busulfan | Small molecule | 3.2 mg/kg | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | 60 mg/m2 | — |
| Background | Cyclosporine | Peptide | — | Intravenous |
| Background | Methylprednisolone | Other / unclassified | 0.5 mg/kg | Intravenous |
| Background | Rabbit Thymoglobulin | Unknown | 2.5 mg/kg | Intravenous |